Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study
- 15 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 152 (2), 373-382
- https://doi.org/10.1007/s11060-021-03711-z
Abstract
Purpose The optimal modality of radiation—intensity-modulated radiation therapy (IMRT) or stereotactic radiosurgery (SRS)—in patients with recurrent WHO grade II meningiomas is not well-established. The purpose of this study was to compare progression-free survival (PFS) in patients undergoing salvage IMRT vs SRS. We compared PFS in those with and without history of prior radiation. Methods Forty-two patients with 71 tumor recurrences treated with IMRT or SRS were retrospectively reviewed. Thirty-two salvage treatments were performed on recurrent tumors never treated with prior radiation (‘radiation-naïve’ cohort), whereas 39 salvage treatments were performed on recurrent tumors previously treated with radiation (‘re-treatment cohort’). Results In the ‘radiation-naïve’ cohort, 3-year PFS for IMRT and SRS was 68.8% and 60.7%, respectively (p = 0.61). The median tumor volume for patients treated with IMRT was significantly larger than for patients treated with SRS (5.7 vs 2.2 cm3; p = 0.04). The 3-year PFS for salvage IMRT or SRS in the ‘re-treatment’ cohort was 45.4% vs 65.8% in the ‘radiation-naïve’ cohort (p = 0.008). When analyzing the outcome of multiple re-treatments, median PFS was 47 months for 1st or 2nd salvage radiation (IMRT or SRS) compared to 16 months for the 3rd or greater salvage radiation treatment (p = 0.003). Conclusion For salvage radiation of recurrent grade II tumors that are ‘radiation-naïve’, comparable 3-year PFS rates were found between IMRT and SRS, despite the IMRT group having significantly larger tumors. Salvage radiation overall was less successful in the ‘re-treatment’ cohort compared with the ‘radiation-naïve’ cohort. Additionally, the effectiveness of radiation significantly declines with successive salvage radiation treatments.Keywords
This publication has 40 references indexed in Scilit:
- Radiotherapy for atypical meningiomasJournal of Neurosurgery, 2011
- Treatment of atypical meningiomaJournal of Clinical Neuroscience, 2010
- Cyberknife Stereotactic Radiosurgery for Treatment of Atypical (Who Grade II) Cranial MeningiomasNeurosurgery, 2010
- LONG-TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATIONNeurosurgery, 2009
- Atypical and Malignant Meningioma: Outcome and Prognostic Factors in 119 Irradiated Patients. A Multicenter, Retrospective Study of the Rare Cancer NetworkInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteriaNeurosurgical Focus, 2008
- Stereotactic radiosurgery for atypical and anaplastic meningiomasJournal of Neuro-Oncology, 2007
- The accuracy of meningioma grading: a 10‐year retrospective auditNeuropathology and Applied Neurobiology, 2005
- The effect of radiosurgeryduring management of aggressive meningiomasSurgical Neurology, 2003
- Postoperative irradiation for subtotally resected meningiomasJournal of Neurosurgery, 1994